drugset / Trial / NCT00428246

Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation

NCT00428246

Completed 24 enrolled Indiana University Abbott · collab
RandomizedSingle-groupTriple-blindTreatment

Summary

The study is about possible protective effects of paricalcitol (Zemplar) upon inflammation, blood pressure and kidney function. Kidney Inflammation occurs when white blood cells become abnormally stimulated and accumulate in the kidney and cause damage to the kidney. The purpose of this study is to determine if paricalcitol helps improve kidney injury, blood pressure control and kidney function in patients with chronic kidney disease. The study will last about 7 weeks and involves about 8 visits to the medical center.

Timeline

Start
2006-11
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Paricalcitol Other / unclassified 1 ug Oral
Comparator Paricalcitol Other / unclassified 2 ug Oral